课题基金 / 基金详情

Regulation of Kidney-Specific Gene Expression

Regulation of Kidney-Specific Gene Expression
肾脏特异性基因表达的调节
批准号:
10629391
负责人:
Peter Igarashi
金额:
$48.03万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-11-18 至 2026-06-30
关键词:
AblationAdhesivesAffectBindingBiochemicalCHD4 geneCell ProliferationCellsChIP-seqChromatin LoopChromatin Remodeling FactorComplexCouplesCyclic AMPCystCystic Kidney DiseasesDNADNA BindingDepositionDiseaseDistalEZH2 geneEnhancersEpithelial CellsEpitheliumFibrosisGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomicsGoalsGrowthHealthHi-CHistone AcetylationHistonesHumanImmunoprecipitationIndividualInheritedKidneyKidney DiseasesKidney FailureLigandsMass Spectrum AnalysisMeasuresMessenger RNAMolecularMusMutant Strains MiceMutationNamesNuRD complexOrganPathogenesisPathway interactionsPhenotypePhosphorylationPlayPolycombPolycystic Kidney DiseasesPolymeraseProteinsRNA Polymerase IIRegulationRenal functionRepressionRoleSignal PathwaySignal TransductionStructureTestingTissue-Specific Gene ExpressionTranscription ElongationTranscriptional RegulationUntranslated RNAUrinary tractWNT Signaling PathwayWNT9A geneWnt proteinsWorkautosomebeta cateninchromatin modificationchromatin remodelingchromosome conformation capturecongenital anomalies of the kidneyderepressionfibrogenesisgene repressiongenome-widehepatocyte nuclear factorhistone methylationhistone modificationimprovedin vivo evaluationindexinginsightinterstitialkidney cellkidney fibrosislipid metabolismlymphoid enhancer-binding factor 1mouse geneticsmouse modelmutantmutant mouse modelnephrogenesisnoveloverexpressionpalmitoylationpromoterrecruitrenal epitheliumtherapeutic targettraffickingtranscription factortranscriptome sequencingurinary

项目摘要

项目成果

Peter Igarashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The purpose of this MERIT renewal is to continue our studies on hepatocyte nuclear factor-1β (HNF-1β) and its roles in kidney-specific gene expression and cystic kidney diseases. HNF-1β is a DNA-binding transcription factor that regulates tissue-specific gene expression in the kidney and other epithelial organs. Mutations of HNF- 1β produce congenital anomalies of the kidney and urinary tract, cystic kidney disease, autosomal dominant tubulointerstitial kidney disease, and inherited tubulopathies. To unravel the pathogenesis of these disorders, we have produced HNF-1β mutant mice that develop phenotypes similar to those seen in affected humans. Analysis of the mutant mice has revealed that HNF-1β plays a central role in the expression of polycystic kidney disease genes, such as PKD2 and PKHD1. During the last project period, we used genome-wide ChIP-seq and RNA-seq to identify transcriptional networks that are directly regulated by HNF-1β. Together with new mutant mouse models, these studies uncovered novel roles of HNF-1β in the regulation of Wnt signaling, cAMP signaling, lipid metabolism, urinary concentration, and expression of noncoding RNAs. Preliminary studies using mass spectrometry revealed that HNF-1β interacts with proteins involved in chromatin remodeling, histone modification, and transcription elongation. In the next project period we will extend this work to further unravel the functions of HNF-1β in the kidney. Specific Aim 1 will use biochemical studies to unravel the molecular mechanisms whereby HNF-1β represses Wnt pathway genes. We will test the hypothesis that HNF-1β forms repressive chromatin loops that exert long-range effects on histone modification, chromatin remodeling, and transcription elongation. Specific Aim 2 will apply mouse genetics to elucidate the roles of dysregulated Wnt signaling in the HNF-1β mutant phenotype. We will determine whether mutations of Wnt pathway genes that are overexpressed in HNF-1β mutant mice improve kidney function and structure. Collectively, the proposed studies will advance our understanding of gene regulation, unravel how mutations of HNF-1β produce kidney abnormalities, and identify potential therapeutic targets for HNF-1β-related cystic kidney diseases.
期刊论文(51)
专著(0)
科研奖励(0)
会议论文
Multiomics analysis reveals that hepatocyte nuclear factor 1β regulates axon guidance genes in the developing mouse kidney.
多组学分析表明,肝细胞核因子1β调节发育中的小鼠肾脏中的轴突引导基因。
DOI: 10.1038/s41598-022-22327-5
发表时间: 2022-10-20
期刊: Scientific reports
影响因子: 4.6
作者: []
通讯作者:
Cloning, sequence, and tissue distribution of a rabbit renal Na+/H+ exchanger transcript.
兔肾 Na /H 交换转录物的克隆、序列和组织分布。
DOI: 10.1016/0167-4781(91)90221-7
发表时间: 1991
期刊: Biochimica et biophysica acta
影响因子: --
作者: [Hildebrandt,F, Pizzonia,JH, Reilly,RF, Rebouças,NA, Sardet,C, Pouysségur,J, Slayman,CW, Aronson,PS, Igarashi,P]
通讯作者: Igarashi,P
DOI: 10.1007/s00467-018-3990-7
发表时间: 2019-08
期刊: Pediatric nephrology (Berlin, Germany)
影响因子: --
作者: [Ferrè S, Igarashi P]
通讯作者: Igarashi P
Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice.
内源性β-连环蛋白的肾小管特异性消融会加重小鼠急性肾损伤
DOI: 10.1038/ki.2012.173
发表时间: 2012-09
期刊: Kidney international
影响因子: 19.6
作者: []
通讯作者:
18
    Regulation of Kidney-Specific Gene Expression
    Regulation of Kidney-Specific Gene Expression
    • 批准号:
      9318506
    • 项目类别:
    • 资助金额:
      $36.59万
    • 财政年份:
      2016
    • 负责人:
      Peter Igarashi
    • 依托单位:
    MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
    • 批准号:
      7832043
    • 项目类别:
    • 资助金额:
      $49.59万
    • 财政年份:
      2009
    • 负责人:
      Peter Igarashi
    • 依托单位:
    MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
    • 批准号:
      7936337
    • 项目类别:
    • 资助金额:
      $48.61万
    • 财政年份:
      2009
    • 负责人:
      Peter Igarashi
    • 依托单位:
    海外基金